Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2005; 30(1): 22-24


Identification of Seronegative pregnant women eligible for Immunization against Rubella

Malik Muhammad Adil, Muhammad Zubair, Ali Yawar Alam, K.S, Raja.




Abstract

Objective: To estimate the frequency of Rubella seropositivity among pregnant women and thereby getting an estimate of seronegative women who should eventually be immunized against Rubella.
Subjects and Methods: A blood sample of 100 consecutive pregnant women coming for their first antenatal check-up at Shifa International Hospital, Islamabad, was collected in the year 2002. Enzyme-Linked immunosorbent assay (ELISA) technique was used to detect IgG antibodies against Rubella.
Results: Out of 100 pregnant women 61(61%) were positive for rubella (IgG antibodies) in the first trimester of pregnancy. Mean age of the study participants was 27 ± 3.27 years. Twenty-five (25%) women were primigravida, while 75 (75%) were multigravida. Majority of the women were housewives belonging to middle and lower middle socioeconomic class.
Conclusion: We found 61% women had positive Rubella antibodies during first antenatal visit. Nearly 40% who were negative should be immunized against rubella, preferably before conception. (Rawal Med J 2005;30:22-24).

Key words: Rubella, Immunization, Pakistan






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.